"This looks and feels like 2000," says investing legend

Our senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says it could be the worst U.S. financial crisis in 200 years. Before the next trading session begins, I highly recommend you review Dan's action plan to secure your gains, even if the market falls from here.

Click here to see how Dan says you could profit from the American "Mega Bubble" of 2025.

VERA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.70%

Insider Buying (Last 12 Months): $4,999,990.00

Insider Selling (Last 12 Months): $45,630,957.61

Vera Therapeutics Insider Trading History Chart

Vera Therapeutics Share Price & Price History

^$44.85

▲ +0.8 (1.82%)

As of 12/16/2024 12:38 PM ET

Days: 30 | 90 | 365

Amazon coin set to soar 25X – starting December 16th?

From True Market Insiders | Ad

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

>3-Cent Amazon Coin<

Vera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2024	Marshall Fordyce	CEO	Sell	17,500	$46.94	$821,450.00	85,942
10/28/2024	Beth C Seidenberg	Director	Sell	15,000	$48.03	$720,450.00	131,553
10/23/2024	Marshall Fordyce	CEO	Sell	19,375	$40.39	$782,556.25	307,972
10/9/2024	Marshall Fordyce	CEO	Sell	15,625	$38.24	$597,500.00	307,972
9/25/2024	Marshall Fordyce	CEO	Sell	23,125	$46.05	$1,064,906.25	307,972
9/18/2024	Beth C Seidenberg	Director	Sell	1,177	$42.01	$49,445.77	160,376
9/11/2024	Marshall Fordyce	CEO	Sell	15,625	$37.50	$585,937.50	307,972
8/21/2024	Marshall Fordyce	CEO	Sell	14,471	$39.76	$575,366.96	322,667
4/10/2024	Joseph R. Young	SVP	Sell	5,714	$40.00	$228,560.00	53,171
4/3/2024	Sean Grant	CFO	Sell	99,828	$39.61	$3,954,187.08	66,337
3/25/2024	Maha Katabi	Director	Sell	340,000	$40.50	$13,770,000.00	2,793,987
3/21/2024	Maha Katabi	Director	Sell	81,009	$44.20	$3,580,597.80	3,547,437
1/30/2024	Maha Katabi	Director	Buy	161,290	$31.00	$4,999,990.00	3,628,446
1/10/2024	Commodore Capital Lp	Major Shareholder	Sell	1,050,000	$18.00	$18,900,000.00	4,400,000
8/21/2023	Celia Lin	Insider	Sell	1,490	$16.65	$24,808.50	11,010
8/21/2023	Marshall Fordyce	CEO	Sell	5,210	$16.66	$86,798.60	243,361
6/23/2023	Sean Grant	CFO	Buy	5,000	$16.60	$83,000.00	5,992
6/20/2023	Commodore Capital Lp	Major Shareholder	Buy	448,217	$15.17	$6,799,451.89	5,450,000
3/30/2023	Beth C Seidenberg	Director	Buy	2,300	$7.24	$16,652.00	1,949,295
3/27/2023	Beth C Seidenberg	Director	Buy	1,633	$7.24	$11,822.92	1,923,087
3/24/2023	Beth C Seidenberg	Director	Buy	1,833	$7.24	$13,270.92	1,921,454
3/20/2023	Beth C Seidenberg	Director	Buy	15,252	$7.21	$109,966.92	1,919,621
3/17/2023	Beth C Seidenberg	Director	Buy	74,045	$7.12	$527,200.40	1,904,369
3/15/2023	Beth C Seidenberg	Director	Buy	32,844	$7.12	$233,849.28	1,770,227
3/10/2023	Beth C Seidenberg	Director	Buy	48,003	$7.16	$343,701.48	1,737,383
3/3/2023	Beth C Seidenberg	Director	Buy	1,000	$7.25	$7,250.00	1,689,380
3/1/2023	Beth C Seidenberg	Director	Buy	100	$7.25	$725.00	1,665,002
2/23/2023	Beth C Seidenberg	Director	Buy	200	$7.24	$1,448.00	1,664,902
2/13/2023	Beth C Seidenberg	Director	Buy	10,072	$7.20	$72,518.40	1,664,702
2/8/2023	Beth C Seidenberg	Director	Buy	45,357	$7.22	$327,477.54	1,654,230
2/6/2023	Patrick G Enright	Director	Buy	1,714,285	$7.00	$11,999,995.00	1,714,285
2/6/2023	Sofinnova Venture Partners X,	Major Shareholder	Buy	285,714	$7.00	$1,999,998.00	3,467,156
2/3/2023	Beth C Seidenberg	Director	Buy	46,163	$7.24	$334,220.12	1,389,315
12/16/2022	Joanne Curley	Insider	Sell	2,212	$19.49	$43,111.88	26,821
11/17/2022	Joanne Curley	Insider	Sell	3,289	$15.85	$52,130.65	27,315
10/18/2022	Joanne Curley	Insider	Sell	8,590	$19.41	$166,731.90	27,809
10/5/2022	Joanne Curley	Insider	Sell	988	$21.64	$21,380.32	27,809
10/4/2022	Marshall Fordyce	CEO	Sell	18,223	$21.19	$386,145.37	181,150
9/20/2022	Joanne Curley	Insider	Sell	15,666	$20.67	$323,816.22	28,797
9/12/2022	Marshall Fordyce	CEO	Sell	16,136	$20.64	$333,047.04	181,150
9/8/2022	Marshall Fordyce	CEO	Sell	15,106	$20.52	$309,975.12	181,150
8/22/2022	Joanne Curley	Insider	Sell	1,630	$18.87	$30,758.10	29,785
8/19/2022	Joanne Curley	Insider	Sell	6,909	$19.20	$132,652.80	29,785
8/17/2022	Carlyle Group Inc.	Major Shareholder	Sell	9,925	$20.25	$200,981.25	2,960,231
8/12/2022	Marshall Fordyce	CEO	Sell	20,528	$20.16	$413,844.48	137,400
8/3/2022	Joanne Curley	Insider	Sell	988	$16.81	$16,608.28	17,285
7/19/2022	Joanne Curley	Insider	Sell	11,444	$16.01	$183,218.44	18,273
7/14/2022	Joanne Curley	Insider	Sell	9,104	$15.14	$137,834.56	18,273
7/7/2022	Joanne Curley	Insider	Sell	9,666	$15.05	$145,473.30	21,023
6/22/2022	Joanne Curley	Insider	Sell	1,545	$15.01	$23,190.45	23,688
6/17/2022	Joanne Curley	Insider	Sell	5,887	$15.04	$88,540.48	23,994
6/15/2022	Sean Grant	CFO	Buy	5,000	$13.60	$68,000.00	2,816
2/10/2022	Patrick G Enright	Director	Buy	333,333	$15.00	$4,999,995.00
2/10/2022	Sofinnova Venture Partners X,	Major Shareholder	Buy	266,666	$15.00	$3,999,990.00

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Altcoin season moves fast, and those who hesitate are left behind. The window is closing.

>> Register for the Workshop Now

SEC Filings (Institutional Ownership Changes) for Vera Therapeutics (NASDAQ:VERA)

99.21% of Vera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Lord Abbett & CO. LLC	426,014	$18.83M	0.1%	+41.1%	0.673%
11/27/2024	Franklin Resources Inc.	8,746	$0.37M	0.0%	-40.1%	0.014%
11/16/2024	Geode Capital Management LLC	1,004,665	$44.42M	0.0%	+2.1%	1.832%
11/15/2024	Barclays PLC	85,395	$3.77M	0.0%	+94.1%	0.135%
11/15/2024	Y Intercept Hong Kong Ltd	30,911	$1.37M	0.1%	+283.1%	0.056%
11/15/2024	Pier Capital LLC	103,463	$4.57M	0.6%	N/A	0.189%
11/15/2024	Wellington Management Group LLP	20,071	$0.89M	0.0%	-82.2%	0.037%
11/15/2024	State Street Corp	1,823,807	$80.61M	0.0%	-15.4%	3.326%
11/15/2024	Quarry LP	2,300	$0.10M	0.0%	-64.6%	0.004%
11/15/2024	Readystate Asset Management LP	47,683	$2.11M	0.0%	-93.8%	0.087%
11/15/2024	Point72 DIFC Ltd	43,789	$1.94M	0.1%	+8.4%	0.080%
11/15/2024	Point72 Asset Management L.P.	171,573	$7.58M	0.0%	+44.2%	0.313%
11/15/2024	HighVista Strategies LLC	22,010	$0.97M	0.3%	+140.2%	0.040%
11/15/2024	Holocene Advisors LP	1,954,528	$86.39M	0.3%	+8.8%	3.565%
11/15/2024	Cinctive Capital Management LP	48,500	$2.14M	0.1%	+39.5%	0.088%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	9,407	$0.42M	0.1%	+109.4%	0.017%
11/14/2024	Verition Fund Management LLC	43,210	$1.91M	0.0%	N/A	0.079%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	61,574	$2.72M	0.0%	+11.8%	0.112%
11/14/2024	FORA Capital LLC	10,622	$0.47M	0.1%	-18.1%	0.019%
11/13/2024	FMR LLC	2,785,284	$123.11M	0.0%	-0.6%	5.080%
11/12/2024	Algert Global LLC	23,164	$1.02M	0.0%	+34.3%	0.042%
11/12/2024	Charles Schwab Investment Management Inc.	361,805	$15.99M	0.0%	+3.1%	0.660%
11/9/2024	Intech Investment Management LLC	10,737	$0.48M	0.0%	N/A	0.020%
11/8/2024	Jennison Associates LLC	447,098	$19.76M	0.0%	+1.3%	0.815%
11/7/2024	First Turn Management LLC	326,494	$14.43M	2.3%	+53.3%	0.595%
11/5/2024	Victory Capital Management Inc.	38,253	$1.69M	0.0%	+13.5%	0.070%
11/5/2024	GSA Capital Partners LLP	12,113	$0.54M	0.0%	-62.6%	0.022%
11/4/2024	Chartwell Investment Partners LLC	19,172	$0.85M	0.0%	+63.5%	0.035%
10/30/2024	AlphaCentric Advisors LLC	7,500	$0.33M	0.2%	N/A	0.014%
10/25/2024	China Universal Asset Management Co. Ltd.	10,545	$0.47M	0.1%	+64.1%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	1,983	$86K	0.0%	+21.4%	0.004%
10/22/2024	Eastern Bank	56,050	$2.48M	0.0%	N/A	0.102%
10/5/2024	Handelsbanken Fonder AB	13,800	$0.61M	0.0%	+19.0%	0.025%
10/3/2024	SG Americas Securities LLC	9,354	$0.41M	0.0%	+117.5%	0.017%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	37,400	$1.35M	0.0%	N/A	0.068%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	4,493	$0.16M	0.0%	N/A	0.008%
8/19/2024	Point72 Asset Management L.P.	119,000	$4.31M	0.0%	-89.9%	0.218%
8/16/2024	Quarry LP	6,500	$0.24M	0.1%	N/A	0.012%
8/16/2024	Algert Global LLC	17,254	$0.62M	0.0%	+38.9%	0.032%
8/16/2024	Driehaus Capital Management LLC	255,133	$9.23M	0.1%	-0.8%	0.466%
8/15/2024	The Manufacturers Life Insurance Company	102,037	$3.69M	0.0%	+28.0%	0.187%
8/15/2024	Deerfield Management Company L.P. Series C	6,191	$0.22M	0.0%	-39.4%	0.011%
8/15/2024	Decheng Capital LLC	69,767	$2.52M	0.8%	N/A	0.128%
8/15/2024	AQR Capital Management LLC	9,682	$0.35M	0.0%	-52.6%	0.018%
8/15/2024	AXA S.A.	246,201	$8.91M	0.0%	-9.5%	0.450%
8/15/2024	Affinity Asset Advisors LLC	375,000	$13.57M	1.6%	-20.2%	0.686%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	4,493	$0.16M	0.0%	N/A	0.008%
8/14/2024	Squarepoint Ops LLC	148,011	$5.36M	0.0%	+316.5%	0.271%
8/14/2024	Cubist Systematic Strategies LLC	53,940	$1.95M	0.0%	+98.8%	0.099%
8/14/2024	First Light Asset Management LLC	1,005,723	$36.39M	3.2%	+130.6%	1.839%
8/14/2024	Point72 DIFC Ltd	40,413	$1.46M	0.1%	+1,932.8%	0.074%
8/14/2024	Marshall Wace LLP	524,578	$18.98M	0.0%	+9.2%	0.959%
8/14/2024	Samlyn Capital LLC	1,231,911	$44.57M	0.7%	+90.8%	2.252%
8/14/2024	Logos Global Management LP	950,000	$34.37M	2.8%	+65.2%	1.733%
8/14/2024	Integral Health Asset Management LLC	500,000	$18.09M	1.7%	+38.9%	0.914%
8/14/2024	Adams Street Partners LLC	13,114	$0.47M	0.2%	N/A	0.024%
8/14/2024	Magnetar Financial LLC	18,021	$0.65M	0.0%	N/A	0.033%
8/14/2024	Avoro Capital Advisors LLC	4,309,590	$155.92M	2.1%	-18.1%	7.878%
8/14/2024	HighVista Strategies LLC	9,162	$0.33M	0.1%	N/A	0.017%
8/14/2024	ProShare Advisors LLC	8,749	$0.32M	0.0%	-19.6%	0.016%
8/14/2024	Profund Advisors LLC	22,396	$0.81M	0.0%	-18.1%	0.041%
8/13/2024	Ensign Peak Advisors Inc	11,750	$0.43M	0.0%	+13.5%	0.021%
8/13/2024	Sei Investments Co.	10,824	$0.39M	0.0%	-2.6%	0.020%
8/13/2024	Public Employees Retirement Association of Colorado	3,718	$0.14M	0.0%	N/A	0.007%
8/12/2024	Seven Eight Capital LP	9,243	$0.33M	0.0%	-85.1%	0.017%
8/12/2024	E Fund Management Co. Ltd.	7,395	$0.27M	0.0%	-10.5%	0.014%
8/9/2024	Renaissance Technologies LLC	147,800	$5.35M	0.0%	+28.5%	0.270%
8/8/2024	Federated Hermes Inc.	290,000	$10.49M	0.0%	N/A	0.530%
8/8/2024	First Turn Management LLC	212,944	$7.70M	1.3%	+80.1%	0.389%
8/8/2024	Nicholas Investment Partners LP	59,129	$2.14M	0.2%	N/A	0.108%
8/8/2024	American Century Companies Inc.	387,380	$14.02M	0.0%	N/A	0.708%
8/6/2024	Candriam S.C.A.	293,760	$10.63M	0.1%	+172.0%	0.537%
8/5/2024	Arizona State Retirement System	9,907	$0.36M	0.0%	+14.4%	0.018%
8/5/2024	Victory Capital Management Inc.	33,707	$1.22M	0.0%	+202.4%	0.062%
8/3/2024	TD Asset Management Inc	154,338	$5.58M	0.0%	+18.4%	0.282%
8/1/2024	Rhumbline Advisers	54,859	$1.99M	0.0%	-5.0%	0.100%
7/29/2024	Principal Financial Group Inc.	7,230	$0.26M	0.0%	-46.3%	0.013%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	7,527	$0.27M	0.0%	+30.0%	0.014%
7/26/2024	Legato Capital Management LLC	7,551	$0.27M	0.0%	N/A	0.014%
7/26/2024	Bank of New York Mellon Corp	165,322	$5.98M	0.0%	+6.3%	0.302%
7/26/2024	EFG Asset Management North America Corp.	31,444	$1.14M	0.2%	+204.0%	0.057%
7/19/2024	William Marsh Rice University	16,397	$0.59M	0.7%	N/A	0.030%
7/12/2024	SG Americas Securities LLC	4,301	$0.16M	0.0%	-64.0%	0.008%
5/30/2024	Cambridge Trust Co.	48,107	$2.07M	0.1%	+386.6%	0.088%
5/24/2024	Cetera Advisors LLC	5,460	$0.24M	0.0%	N/A	0.010%
5/20/2024	Virtu Financial LLC	8,704	$0.38M	0.0%	N/A	0.016%
5/17/2024	Artal Group S.A.	506,019	$21.82M	0.6%	N/A	0.929%
5/16/2024	California State Teachers Retirement System	32,359	$1.40M	0.0%	+18.7%	0.059%
5/16/2024	Jacobs Levy Equity Management Inc.	20,196	$0.87M	0.0%	-1.3%	0.037%
5/16/2024	Kynam Capital Management LP	1,526,787	$65.84M	6.9%	-58.2%	2.804%
5/16/2024	Bayesian Capital Management LP	13,422	$0.58M	0.1%	N/A	0.025%
5/15/2024	First Light Asset Management LLC	436,133	$18.81M	1.4%	N/A	0.801%
5/15/2024	Price T Rowe Associates Inc. MD	2,393,029	$103.19M	0.0%	N/A	4.395%
5/15/2024	Avoro Capital Advisors LLC	5,265,000	$227.03M	2.7%	N/A	9.669%
5/15/2024	Affinity Asset Advisors LLC	470,000	$20.27M	2.5%	N/A	0.863%
5/14/2024	Platinum Investment Management Ltd.	153,932	$6.64M	0.3%	-23.2%	0.283%
5/14/2024	American International Group Inc.	19,764	$0.85M	0.0%	+17.6%	0.036%
5/13/2024	Seven Eight Capital LP	61,968	$2.67M	0.3%	N/A	0.114%
5/13/2024	Ameritas Investment Partners Inc.	4,000	$0.17M	0.0%	+20.8%	0.007%
5/10/2024	Vanguard Group Inc.	2,148,714	$92.65M	0.0%	+31.5%	3.946%

Data available starting January 2016

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Today's Range

Now: $44.85

$43.62

$45.27

50 Day Range

MA: $45.00

$38.64

$49.75

52 Week Range

Now: $44.85

$14.20

$51.61

Volume

82,166 shs

Average Volume

873,220 shs

Market Capitalization

$2.84 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Vera Therapeutics?: Vera Therapeutics' top insider shareholders include:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Marshall Fordyce (CEO)
Sean Grant (CFO)
Joseph R Young (SVP)
Joanne Curley (Insider)
Celia Lin (Insider)
Learn More about top insider investors at Vera Therapeutics.
Who are the major institutional investors of Vera Therapeutics?: Vera Therapeutics' top institutional shareholders include:
FMR LLC — 5.08%
Holocene Advisors LP — 3.56%
State Street Corp — 3.33%
Geode Capital Management LLC — 1.83%
Jennison Associates LLC — 0.82%
Lord Abbett & CO. LLC — 0.67%
Learn More about top institutional investors of Vera Therapeutics stock.
Which major investors are selling Vera Therapeutics stock?: During the previous quarter, VERA stock was sold by these institutional investors:
Readystate Asset Management LP
State Street Corp
Wellington Management Group LLP
GSA Capital Partners LLP
FMR LLC
Belvedere Trading LLC
Franklin Resources Inc.
Quarry LP
In the previous year, company insiders that have sold Vera Therapeutics company stock include:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Marshall Fordyce (CEO)
Learn More investors selling Vera Therapeutics stock.
Which major investors are buying Vera Therapeutics stock?: During the previous quarter, VERA stock was purchased by institutional investors including:
Holocene Advisors LP
Lord Abbett & CO. LLC
First Turn Management LLC
Pier Capital LLC
Eastern Bank
Point72 Asset Management L.P.
Verition Fund Management LLC
Barclays PLC
Within the previous year, these company insiders have bought Vera Therapeutics stock:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Marshall Fordyce (CEO)
Learn More investors buying Vera Therapeutics stock.